Offering mifepristone as an abortion option

Helen C. Pymar, Mitchell D Creinin

Research output: Contribution to journalArticle

Abstract

While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug still need to familiarize themselves with the research on its advantages and disadvantages.

Original languageEnglish (US)
Pages (from-to)113-119
Number of pages7
JournalContemporary Ob-Gyn
Volume46
Issue number2
StatePublished - 2001
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this